Skip to main content

Blue Owl Capital Holdings LP

Position in ENGN — enGene Therapeutics Inc.

CIK 1858703 New York, NY

Position in ENGN

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$0
-$30,075,363 QoQ
Shares Held
511,177
-88.4% QoQ
Ownership
0.763%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
11 quarters on record

Common Shares in ENGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Blue Owl Capital Holdings LP holds $278,984,828 across 30 Biotechnology names. ENGN ranks #29 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ENGN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 ENGNW 511,177
2026-06-30 $884,336 511,177
2026-03-31 $30,075,363 4,416,353
2025-12-31 $30,349,261 3,360,937
2025-09-30 $22,389,463 3,278,106
2025-06-30 $13,570,305 3,728,106
2025-03-31 $14,691,613 3,279,378
2024-12-31 $21,013,833 3,159,975
2024-09-30 $20,189,195 3,058,969
2024-06-30 $23,101,868 2,449,827
2024-03-31 $41,719,882 2,461,350
2023-12-31 $11,396,834 1,234,760